Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CONTINUING EDUCATION (CE)

Review Education Group

Optic Nerve Disorders: How They Manifest and What They Mean (CE)

Optometry July 24th 2023

Dentaltown

COVID-19 – What You Need To Know

Dentistry July 17th 2023

Pharmacy Today

Pharmacists Increasing Access to Reproductive Health Care

Clinical Pharmacology June 30th 2023

Review Education Group

Choroidal Folds: A New Wrinkle in Retinal Care

Optometry June 26th 2023

Decisions in Dentistry

The Impact of Porphyromonas Gingivalis on Systemic Health

Dentistry June 16th 2023

Pharmacy Today

Gender-affirming Care and Pharmacy Practice

Explore a course created to equip pharmacists with the knowledge and abilities to assist patients who identify as transgender or gender nonconforming (TGND). The educational program “Gender-Affirming Care in Pharmacy Practice” is a comprehensive guide for pharmacists to better serve transgender and gender-diverse (TGD) patients. It provides a deep understanding of the terminology related to TGD patient populations, including definitions of gender identity, gender expression, and various gender identities. The program emphasizes the importance of gender-affirming care, which includes social, medical, psychological, and behavioral care that aligns with a person’s gender identity. It also provides guidance on how to communicate inclusively with TGD patients, such as introducing oneself with name and pronouns, asking open-ended questions, and avoiding unnecessary or invasive questions. Furthermore, the program highlights the health disparities faced by TGD individuals seeking gender-affirming care, such as higher levels of unemployment and healthcare discrimination. It also discusses the coverage of gender-affirming care by Medicaid, which varies across states. The program provides detailed information on hormone therapy for TGD patients, including testosterone and estrogen hormone therapy. It discusses the potential side effects, contraindications, and the importance of contraception for patients at risk of becoming pregnant while on testosterone therapy. Lastly, the […]

Clinical Pharmacology May 31st 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form